Roche Analyst Event at ASCO 2019

Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Agenda:

Welcome
Karl Mahler, Head of Investor Relations
ASCO 2019 Key readouts across tumor types
Hematology
Nancy Valente, M.D., Global Head of Product Development - Hematology
Breast cancer, lung cancer & pan-tumor
Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
Roche Oncology strategy update
Bill Anderson, CEO Roche Pharmaceuticals
Q&A

Please register to access the webcast

First Name

Last name

Corporate Email

Company Name

Job Role

Country

* Mandatory

The registration form for the webcast is not available.

Please come back 30 minutes before the webcast start date and fill in the registration form.